You searched for
We found 9 articles

SMOOTH – Blood Pressure Control in Diabetic/Obese Patients

The primary objective of the SMOOTH study was to demonstrate that, when combined with hydrochlorothiazide (12.5 mg), telmisartan (80 mg)…

01 Jan 2013

Cognitive Behavioural Therapy for Obesity

The purpose of this study is to evaluate the effectiveness of a cognitive behavioural treatment (CBT) designed to help obese…

01 Jan 2013

A Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis

The purpose of this study is to compare the efficacy of visilizumab to placebo in subjects with intravenous steroid-refractory ulcerative…

01 Jan 2013

Study of Dexlansoprazole vs Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive Esophagitis.

A 6-month study to assess the ability of daily treatment with dexlansoprazole 30mg, 60 mg or placebo in maintaining healing…

01 Jan 2013

A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia

This study will determine whether 8 weekly monitoring of hemoglobin and iron parameters in the correction phase of NeoRecormon therapy…

01 Jan 2013

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone

The purpose of this clinical research study is to learn whether Abatacept can treat and prevent lupus flares; specifically, active…

01 Jan 2013

A Study of the Safety and Efficacy of Intravenous CNTO 148 (Golimumab) in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

The primary purpose of this study is to assess the clinical effectiveness and safety of intravenous (IV- injection directly into…

01 Jan 2013

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

The purpose of this study is to assess the tolerability and safety of KRX-101 in treating persistent microalbuminuria in type…

01 Jan 2013

A Comparison of AZD6140 and Clopidogrel in Patients With Acute Coronary Syndrome

AZD6140 is a new, reversible, anti-platelet medication. Anti-platelet medications work to prevent the formation of blood clots. AZD6140 is being…

01 Jan 2013